AI Visibility Scorecard
Aurora Kinase Inhibitor at9283 in Oncology Clinical Trials
at9283.com · Healthcare
Borderline visible. AI bots can crawl Aurora Kinase Inhibitor at9283 in Oncology Clinical Trials, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 3 times
ChatGPT · Claude
#780,211 of 925,367 in Healthcare for AI visibility
<1
AI Naming Predictability
iRarely named · <1/100
Healthcare average 11
Top 83% of Healthcare
See what's behind this score →3.5
-
Network Authority
iNot connected yet
0 relationships on record. Businesses in Healthcare average 3. Claim your page and Engagemii is your first.
See what's behind this score →5
0
About Aurora Kinase Inhibitor at9283 in Oncology Clinical Trials
from our crawl and measurement
Aurora Kinase Inhibitor at9283 in Oncology Clinical Trials describes itself simply: "test; MALDI TOF mass spectrometry and PCR amplification of the spa gene showed excellent concordance with the tube test, as all tube coagulase-positive strains were identified as S." When AI engines look at it, they find little to work with. It scores 3.5 out of 10.
Our crawl found a sitemap. It is missing structured data describing the business, an llms.txt file and a heading structure that lays out what it offers.
- Company ·
- Aurora Kinase Inhibitor at9283 in Oncology Clinical Trials
- Website ·
- at9283.com
- Industry ·
- Healthcare
- Site status ·
- Live (The website showed an active business site when last checked (Nov 1, 2026).)
- Last scored ·
- Aug 26, 2026
The 6 on-page signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Good
Clear headings and answer-style content.
Entity Clarity
Weak
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Fair
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Fair
Sitemaps and entity links AI can follow.
The 6 off-page signals AI reads
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can read your site and name it in answers. At 3.5/10, Aurora Kinase Inhibitor at9283 in Oncology Clinical Trials is crawlable but under-signaled - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for Aurora Kinase Inhibitor at9283 in Oncology Clinical Trials
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
How to Get Your Company Named by ChatGPT, Gemini, and Claude
When a buyer asks ChatGPT which company to use, two different things can happen. ChatGPT can name a company in its answer. Or it can link to a web page as a source. Most advice about AI visibility is about the second one. Our data says the first one is what matters.
Continue reading in your free Engagemii portalSign up free to read the full article and get your AEO fix list for Aurora Kinase Inhibitor at9283 in Oncology Clinical Trials.
Source & Attribution
Scored by Engagemii on August 26, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/at9283
Cite this score: Engagemii (2026). "AEO Score for Aurora Kinase Inhibitor at9283 in Oncology Clinical Trials." Retrieved from https://engagemii.com/aeo/brands/at9283
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform